In vitro anti-human immunodeficiency virus activities of Z- and E- methylenecyclopropane nucleoside analogues and their phosphoro-L-alaninate diesters

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 6, 1999, Pages 1487-1490

  Uchida, Hiroyuki ^a   Kodama, Eiichi N ^a   Yoshimura, Kazuhisa ^a   Maeda, Yosuke ^a   Kosalaraksa, Pope ^a   Maroun, Victor ^a   Qiu, Yao Ling ^b   Zemlicka, Jiri ^b   Mitsuya, Hiroaki ^a,c,d  

^a Vascular Medicine Branch   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2',3' DIDEOXYNUCLEOSIDE DERIVATIVE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CYCLOPROPANE DERIVATIVE; DIDANOSINE; ESTER DERIVATIVE; NUCLEOSIDE ANALOG; QYL 609; QYL 685; UNCLASSIFIED DRUG; ZIDOVUDINE;

ANTIBIOTIC RESISTANCE; ANTIVIRAL ACTIVITY; ARTICLE; DRUG INHIBITION; DRUG POTENCY; DRUG POTENTIATION; DRUG STRUCTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0033026673     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.6.1487     Document Type: Article

References (27)

1. Ashton, W. T., L. F. Canning, G. F. Reynolds, R. L. Tolman, J. D. Karkas, R. Liou, M. E. Davies, C. M. DeWitt, H. C. Perry, and A. K. Field. 1985. Synthesis and antiherpetic activity of (S)-, (R)-, and (+/-)-9-[(2,3-dihydroxy-1-propoxy)methyl]guanine, linear isomers of 2′-nor-2′-deoxyguanosine. J. Med. Chem. 28:925-933.
2. Ashton, W. T., L. C. Meurer, C. L. Cantone, A. K. Field, J. Hannah, J. D. Karkas, R. Liou, G. F. Patel, H. C. Perry, and A. F. Wagner. 1988. Synthesis and antiherpetic activity of (+/-)-9-[[(Z)-2-(hydroxymethyl)cyclopropyl] methyl]guanine and related compounds. J. Med. Chem. 31:2304-2315.
3. Baba, M., S. Shigeta, S. Yuasa, H. Takashima, K. Sekiya, M. Ubasawa, H. Tanaka, T. Miyasaka, R. T. Walker, and E. De Clercq. 1994. Preclinical evaluation of MKC-442, a highly potent and specific inhibitor of human immunodeficiency virus type I in vitro. Antimicrob. Agents Chemother. 38:688-692.
4. Balzarini, J., A. Karlsson, S. Aquaro, C. F. Perno, D. Cahard, L. Naesens, E. De Clercq, and C. McGuigan. 1996. Mechanism of anti-HIV action of masked alaninyl d4T-MP derivatives. Proc. Natl. Acad. Sci. USA 93:7295-7299.
5. Barrish, J. C., and R. Zahler. 1993. Antiviral agents. Annu. Rep. Med. Chem. 28:131-140.
6. Cheng, C., T. Shimo, K. Somekawa, and M. Baba. 1998. 9-Hydroxymethyl-cyclopropylidenemethylenyladenine: the design, facile synthesis, isomer separation and anti-HIV-1 activities. Tetrahedron 54:2031-2040.
7. Clavel, F., D. Guetard, F. Brun-Vezinet, S. Chamaret, M. A. Key, M. O. Santos-Ferreira, A. G. Laurent, C. Dauguet, C. Katlama, C. Rouzious, D. Klatzmann, J. L. Champalimaud, and L. Montagnier. 1986. Isolation of a new human retrovirus from West African patients with AIDS. Science 233:343-346.
8. Daluge, S. M., S. S. Good, M. B. Faletto, W. H. Miller, M. H. St. Clair, L. R. Boone, M. Tisdale, N. R. Parry, J. E. Reardon, R. E. Dornsife, D. R. Averett, and T. A. Krenitsky. 1997. 1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity. Antimicrob. Agents Chemother. 41:1082-1093.
9. De Clercq, E. 1994. HIV resistance to reverse transcriptase inhibitors. Biochem. Pharmacol. 47:155-169.
10. De Clercq, E. 1997. In search of a selective antiviral chemotherapy. Clin. Microbiol. Rev. 10:674-693.
11. Decks, S. G., A. Collier, J. Lalezari, A. Pavia, D. Rodrigue, W. L. Drew, J. Toole, H. S. Jaffe, A. S. Mulato, P. D. Lamy, W. Li, J. M. Cherrington, N. Hellmann, and J. Kahn. 1997. The safety and efficacy of adefovir dipivoxil, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults: a randomized, double-blind, placebo-controlled trial. J. Infect. Dis. 176:1517-1523.
12. Hayashi, S., S. Phadtare, J. Zemlicka, M. Matsukura, H. Mitsuya, and S. Broder. 1988. Adenallene and cytallene: acyclic nucleosides that inhibit replication and cytopathic effect of human immunodeficiency virus (HIV) in vitro. Proc. Natl. Acad. Sci. USA 85:6127-6131.
13. Kodama, E., S. Shigeta, T. Suzuki, and E. De Clercq. 1996. Application of a gastric cancer cell line (MKN-28) for anti-adenovirus screening using the MTT method. Antivir. Res. 31:159-164.
14. Marquez, V. E., C. K.-H. Tseng, H. Mitsuya, S. Aoki, J. A. Kelley, H. J. Ford, J. S. Roth, S. Broder, D. G. Johns, and J. S. Driscoll. 1990. Acid-stable 2′-β-fluoro purine dideoxynucleosides as active agents against HIV. J. Med. Chem. 33:978-985.
15. Mitsuya, H. 1997. Nucleoside analogues and their antiretroviral activity, p. 3-22. In H. Mitsuya (ed.), Anti-HIV nucleosides: past, present and future. R. G. Langes Company, Austin, Tex.
16. Mitsuya, H., and J. Erickson. 1998. Discovery and development of antiretroviral therapeutics for HIV infection, p. 751-780. In T. C. Merigan (ed.), Textbook of AIDS medicine, Williams & Wilkins, Baltimore, Md.
17. Moravek, J., and H. Mitsuya. Unpublished data.
18. Pauwels, R., J. Balzarini, M. Baba, R. Snoeck, D. Schols, P. Herdewijn, J. Desmyter, and E. De Clercq. 1988. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J. Virol. Methods 20:309-321.
19. Qiu, Y. L., M. B. Ksebati, R. G. Ptak, B. Y. Fan, J. M. Breitenbach, J.-S. Lin, Y. C. Cheng, E. R. Kern, J. C. Drach, and J. Zemlicka. 1998. (Z)- and (E)-2-[(hydroxymethyl)cyclopropylidene]methyladenine and -guanine. New nucleoside analogues with a broad-spectrum antiviral activity. J. Med. Chem. 41:10-23.
20. Qiu, Y. L., R. G. Ptak, J. M. Breitenbach, J.-S. Lin, Y.-C. Cheng, E. R. Kern, J. C. Drach, and J. Zemlicka. 1998. (Z)- and (E)-2-[(hydroxymethyl)cyclopropylidene]methylpurines and pyrimidines as antiviral agents. Antivir. Chem. Chemother. 9:341-352.
21. Qiu, Y.-L., R. G. Ptak, J. M. Breitenbach, J.-S. Lin, Y.-C. Cheng, J. C. Drach, E. R. Kern, and J. Zemlicka. Synthesis and antiviral activity of phosphoralaninate derivatives of methylenecyclopropane analogues of nucleosides. Antivir. Res., in press.
22. Richman, D. D., V. A. Johnson, D. L. Mayers, T. Shirasaka, M. C. O'Brien, and H. Mitsuya. 1993. In vitro evaluation of experimental agents for anti-HIV activity, p. 12.9.1-12.9.21. In J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, Current protocols in immunology. John Wiley & Sons, Inc., New York, N.Y.
23. Shirasaka, T., S. Chokekijchai, A. Yamada, G. Gosselin, J.-L. Imbach, and H. Mitsuya. 1995. Comparative analysis of anti-human immunodeficiency virus type 1 activities of dideoxynucleoside analogs in resting and activated peripheral blood mononuclear cells. Antimicrob. Agents Chemother. 39: 2555-2559.
24. Shirasaka, T., M. F. Kavlick, T. Ueno, W.-Y. Gao, E. Kojima, M. L. Alcaide, S. Chokekijchai, B. M. Roy, E. Arnold, R. Yarchuan, and H. Mitsuya. 1995. Emergence of human immunodeficiency virus type-1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides. Proc. Natl. Acad. Sci. USA 92:2398-2402.
25. Shirasaka, T., R. Yarchoan, M. C. O'Brien, R. N. Husson, B. D. Anderson, E. Kojima, T. Shimada, S. Broder, and H. Mitsuya. 1993. Changes in drug sensitivity of human immunodeficiency virus type 1 during therapy with azidothymidine, dideoxycytidine, and dideoxyinosine: an in vitro comparative study. Proc. Natl. Acad. Sci. USA 90:562-566.
26. Tanaka, H., M. Baba, S. Saito, T. Miyasaka, H. Takasha, K. Sekiya, M. Ubasawa, I. Nitta, R. T. Walker, H. Nakashima, and E. De Clercq. 1991. Specific anti-HIV-1 "acyclonucleosides" which cannot be phosphorylated: synthesis of some deoxy analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine. J. Med. Chem. 34:1508-1511.
27. Tanaka, M., R. V. Srinivas, T. Ueno, M. F. Kavlick, F. K. Hui, A. Fridland, J. S. Driscoll, and H. Mitsuya. 1997. In vitro induction of human immunodeficiency virus type 1 (HIV-1) variants resistant to 2′-β-fluoro-2′,3′-dideoxyadenosine (F-ddA). Antimicrob. Agents Chemother. 41:1313-1318.